Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, introduced two new variable-angle gamma cameras at this month's Radiological Society of North America meeting in Chicago: Forte and Vertex V60. ADAC hopes Forte, a new open-gantry camera, will
Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, introduced two new variable-angle gamma cameras at this month's Radiological Society of North America meeting in Chicago: Forte and Vertex V60. ADAC hopes Forte, a new open-gantry camera, will hone its competitive edge against the open-style systems that have been introduced recently by other companies.
ADAC was one of the pioneers of the variable-angle segment when it introduced its Genesys Vertex camera in 1992, with a detector configuration based on a dual-ring design that supports the detector heads. Gamma camera introductions since then from companies like SMV, Siemens, Elscint, and Picker feature open-style gantries, which increase versatility.
ADAC's Forte is a dual-head camera with an open gantry design that ADAC calls FreeDome. It can image patients on hospital beds, gurneys, and wheelchairs without hindrance from the detector arms or gantry feet. Forte also includes an automated collimator exchanger called ColliMate.
Forte employs the same imaging chain as Vertex, but includes several enhancements that ADAC introduced at the RSNA meeting. The company's Epix HP digital detectors improve count rates by 25% to 60%, according to Mohamed Elmandjra, vice president of marketing. ADAC also has upgraded the computer workstation it is using to a Sun Microsystems Ultra 60.
Production volumes of Forte will begin in the first quarter of 1999, and the system will cost 20% more than the previous Vertex model. ADAC's Molecular Coincidence Detection module is now available on Forte, while the company's Vantage nonuniform attenuation correction and MCD/AC protocols are six to nine months away.
The company's second new camera, Vertex V60, is the next generation of its Vertex dual-detector gamma camera, which includes the Epix HP detectors and an Ultra 60 computer. Vertex V60 also offers MCD/AC for PET-like imaging and Vantage attenuation correction options. It will carry the same price as the previous Vertex model.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.